Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21384693rdf:typepubmed:Citationlld:pubmed
pubmed-article:21384693lifeskim:mentionsumls-concept:C0040845lld:lifeskim
pubmed-article:21384693lifeskim:mentionsumls-concept:C0022203lld:lifeskim
pubmed-article:21384693lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:21384693lifeskim:mentionsumls-concept:C0008565lld:lifeskim
pubmed-article:21384693pubmed:issue1lld:pubmed
pubmed-article:21384693pubmed:dateCreated2011-3-8lld:pubmed
pubmed-article:21384693pubmed:abstractTextReversed-phase HPLC methods capable of separating several retinoic acid isomers are generally not designed for simultaneous analysis of isomers of other classes of retinoids. A reversed-phase HPLC method is presented which allows the separation of at least four retinoic acid (RA) isomers (13-cis-RA, 9,13-dicis-RA, 9-cis-RA, all-trans-RA)and of all isomers of retinoyl-beta-D-glucuronide (RAG), which have been observed in vivo (13-cis-RAG, 9-cis-RAG,all-trans-RAG). The recovery of retinoids was generally between 80 and 90%. Intra-day reproducibility (expressed as relative standard deviation) was less than or equal to 7%. As little as 0.25 ng of RA isomers and of all-trans-RAG could be detected. This method allowed the study of the metabolism of 9-cis-retinoids, where isomerization reactions play a predominant role.lld:pubmed
pubmed-article:21384693pubmed:languageenglld:pubmed
pubmed-article:21384693pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21384693pubmed:citationSubsetIMlld:pubmed
pubmed-article:21384693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21384693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21384693pubmed:statusMEDLINElld:pubmed
pubmed-article:21384693pubmed:monthNovlld:pubmed
pubmed-article:21384693pubmed:issn0021-9673lld:pubmed
pubmed-article:21384693pubmed:authorpubmed-author:ODAFFlld:pubmed
pubmed-article:21384693pubmed:authorpubmed-author:SassJ OJOlld:pubmed
pubmed-article:21384693pubmed:issnTypePrintlld:pubmed
pubmed-article:21384693pubmed:day11lld:pubmed
pubmed-article:21384693pubmed:volume685lld:pubmed
pubmed-article:21384693pubmed:ownerNLMlld:pubmed
pubmed-article:21384693pubmed:authorsCompleteYlld:pubmed
pubmed-article:21384693pubmed:pagination182-8lld:pubmed
pubmed-article:21384693pubmed:meshHeadingpubmed-meshheading:21384693...lld:pubmed
pubmed-article:21384693pubmed:meshHeadingpubmed-meshheading:21384693...lld:pubmed
pubmed-article:21384693pubmed:meshHeadingpubmed-meshheading:21384693...lld:pubmed
pubmed-article:21384693pubmed:meshHeadingpubmed-meshheading:21384693...lld:pubmed
pubmed-article:21384693pubmed:meshHeadingpubmed-meshheading:21384693...lld:pubmed
pubmed-article:21384693pubmed:meshHeadingpubmed-meshheading:21384693...lld:pubmed
pubmed-article:21384693pubmed:meshHeadingpubmed-meshheading:21384693...lld:pubmed
pubmed-article:21384693pubmed:meshHeadingpubmed-meshheading:21384693...lld:pubmed
pubmed-article:21384693pubmed:meshHeadingpubmed-meshheading:21384693...lld:pubmed
pubmed-article:21384693pubmed:meshHeadingpubmed-meshheading:21384693...lld:pubmed
pubmed-article:21384693pubmed:year1994lld:pubmed
pubmed-article:21384693pubmed:articleTitleSingle-run analysis of isomers of retinoyl-beta-D-glucuronide and retinoic acid by reversed-phase high-performance liquid chromatography.lld:pubmed
pubmed-article:21384693pubmed:affiliationlnstitut fiir Toxikologie und Emhr~opharmakologie, Freie Umversiriit Berlin. Garystrasse 5, D-14195 Berlin, Germany.lld:pubmed
pubmed-article:21384693pubmed:publicationTypeJournal Articlelld:pubmed